A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
about
Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives.Lovastatin may reduce the risk of erectile dysfunction following radiation therapy for prostate cancer.Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016.
P2860
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
@en
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
@nl
type
label
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
@en
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
@nl
prefLabel
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
@en
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
@nl
P2093
P2860
P1476
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
@en
P2093
Aiping Wang
Arun Sanyal
Baruch M Grob
Diane Holdford
Drew Moghanaki
Michael G Chang
Mihaela Rosu
Mitchell S Anscher
Nitai D Mukhopadhyay
Ross B Mikkelsen
P2860
P356
10.1097/COC.0000000000000320
P577
2016-07-19T00:00:00Z